The Role of Protease-Activated Receptor 2 in Hepatocellular Carcinoma after Hepatectomy
<i>Background and Objectives</i>: Protease activated receptor-2 (PAR2) is elevated in a variety of cancers and has been promoted as a potential therapeutic target. However, the clinical and prognostic values of PAR2 in hepatocellular carcinoma (HCC) are poorly characterized. This study a...
Main Authors: | Ming-Chao Tsai, Chih-Che Lin, Ding-Wei Chen, Yueh-Wei Liu, Yi-Ju Wu, Yi-Hao Yen, Pao-Yuan Huang, Chih-Chien Yao, Ching-Hui Chuang, Chang-Chun Hsiao |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-06-01
|
Series: | Medicina |
Subjects: | |
Online Access: | https://www.mdpi.com/1648-9144/57/6/574 |
Similar Items
-
A Longitudinal Study of AFP Trajectories and Clinical Outcomes in Intermediate-Stage Hepatocellular Carcinoma After Hepatectomy
by: Yang H, et al.
Published: (2024-01-01) -
Reappraisal of safety and oncological outcomes of laparoscopic repeat hepatectomy in patients with recurrent hepatocellular carcinoma: it is feasible for the pioneer surgical team
by: Yi Chan Chen, et al.
Published: (2024-11-01) -
PIVKA‐II combined with tumor burden score to predict long‐term outcomes of AFP‐negative hepatocellular carcinoma patients after liver resection
by: Zhan‐cheng Qiu, et al.
Published: (2024-01-01) -
Statin use is associated with a lower risk of recurrence after curative resection in BCLC stage 0-A hepatocellular carcinoma
by: Shih-Yu Yang, et al.
Published: (2021-01-01) -
The predictive value of the modified AFP model for liver transplantation outcomes in multinodular hepatocellular carcinoma patients
by: Jingrui Wang, et al.
Published: (2023-03-01)